Chemistry - A European Journal · 2011 · 36 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyTherapeutic Nuclear MedicineRadiopharmaceutical DesignRadiopharmaceuticalsRadiotracer DevelopmentTargeted Radionuclide TherapyTargeted RadiopharmaceuticalsTumor ImagingBifunctional ChelatorsBiological Evaluation ReportCopper-64 ChemistryCopper-64 RadiopharmaceuticalsTargeted Radiopharmaceutical TherapyTumor Targeting Specificity
A novel bifunctional chelator: The sarcophagine motif was used in the development of a novel bifunctional chelator for 64Cu radiopharmaceuticals (see figure). The high tumor-targeting efficiency and great stability of the 64Cu–BaBaSar–RGD2 conjugate were validated in a U87MG glioma xenograft mouse model. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
16
Adam Prasanphanich, Prasant Kumar Nanda, Tammy L. Rold et al. · Proceedings of the National Academy of Sciences · 2007 · 212 citations · Full text
Medicine, Oncology, Pharmacology +17
Katrina S. Woodin, K.J. Heroux, C. Andrew Boswell et al. · European Journal of Inorganic Chemistry · 2005 · 172 citations
Nadine M. Di Bartolo, Alan M. Sargeson, Therese M. Donlevy et al. · Journal of the Chemical Society Dalton Transactions · 2001 · 145 citations